18.06.2015 Views

Web-economic-crisis-health-systems-and-health-web

Web-economic-crisis-health-systems-and-health-web

Web-economic-crisis-health-systems-and-health-web

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Country profiles of <strong>health</strong> system responses to the <strong>crisis</strong> | Cyprus<br />

359<br />

User charges<br />

• Introduction of a co-payment of €1 per prescription in private pharmacies<br />

(2012).<br />

• Introduction of new user charges of €10 for emergency department<br />

use, €0.50 per laboratory test (capped at €10 per referral), €0.50 per<br />

prescribed drug (capped at €10 per prescription) (from 1 August 2013).<br />

• Co-payments for a GP visit increased from €3 to €6 <strong>and</strong> for a specialist<br />

visit from €2 to €6. Beneficiaries over 65 years have to pay these copayments<br />

(previously they did not pay) (from 1 August 2013);<br />

• User charges increased for non-beneficiaries. More specifically they have<br />

to pay €15 for a GP visit <strong>and</strong> €30 for a specialist visit, instead of €14.5 <strong>and</strong><br />

€15, respectively. Additionally non-beneficiaries have to pay 30% more<br />

for inpatient hospitalization <strong>and</strong> for all medical procedures, examinations<br />

<strong>and</strong> laboratory tests during their hospitalization (from 1 August 2013).<br />

Changes to <strong>health</strong> service planning, purchasing <strong>and</strong> delivery<br />

Prices of medical goods<br />

• Wholesale prices of prescription medicines in 10 EU countries to be<br />

considered when pricing; prices of new drugs costing over €10 to be updated<br />

every 12 months for the first two years <strong>and</strong> then every two years (2012).<br />

• Reduction of the profit cap from 37% to 33% for medical products<br />

of €50–250 (giving pharmacists a margin of around 25% of the retail<br />

price) <strong>and</strong> from 37% to 25% for products costing over €250 (pharmacist<br />

margin of around 20%) (2012).<br />

• VAT introduced for all pharmaceuticals at 5% (2011).<br />

• Introduction of a new surveillance mechanism to monitor polypharmacy<br />

in the public sector (2010).<br />

Salaries <strong>and</strong> motivation of <strong>health</strong> sector workers<br />

• Reduction in the salaries of all public sector <strong>health</strong> professionals (2011,<br />

2012).<br />

• Additional scaled reductions in remuneration of public sector employees<br />

<strong>and</strong> pension recipients (2012).<br />

• Overtime rates reduced (2012).<br />

Payment to providers<br />

• In accordance with the MoU, the Ministry of Health is required to move<br />

from national case-based payment for hospitals to a DRG system (2013).

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!